Latest Umbilical cord Stories
COVINA, Calif., Dec. 7, 2010 /PRNewswire/ -- California-based StemCyte, Inc. announces the launching of its new website, www.StemCyte.com, a comprehensive resource on cord blood banking and its transplant and research initiatives. In an effort to provide the most comprehensive source of cord blood banking information and education online, StemCyte's new website includes extensive information for customers, physicians, and the general public on the lifesaving medical resource of umbilical...
LAS VEGAS, Nov. 24, 2010 /PRNewswire/ -- On this day before Thanksgiving, a day when our entire nation gives thanks for its blessing, Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, would like to share with its investors a post from its web site by Dr. Geoffrey O'Neill, CBAI Vice President,...
LAS VEGAS, Nov. 22, 2010 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today said revenues for the third quarter ended September 30, 2010, increased 14 percent to $958,449 compared to $838,238 in the same period in 2009. The Company also announced that revenues for...
(Ivanhoe Newswire) "“ Umbilical cord stem cells may be useful in the treatment of rheumatoid arthritis (RA), according to in vitro experiments done on animals.The researchers show that mesenchymal stem cells (MSCs) taken from the umbilical cord blood can suppress inflammation and weaken collagen-induced arthritis."Very little is known about umbilical cord MSCs, and there has been no previous report about their use in the treatment of RA. MSCs can exert profound immunosuppression, which...
Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.A number of studies in the West have shown that heavy bleeding following childbirth has become more common in recent years. In her thesis, midwife and researcher Elisabeth Jangsten decided to look at how heavily women bleed after giving birth in Angola and Sweden...
Personal view: Why do obstetricians and midwives still rush to clamp the cord?Obstetricians and midwives should wait a few minutes before clamping the umbilical cords of newborn infants so that babies are not harmed by the procedure, argues Dr David Hutchon in an article published on bmj.com today.Hutchon, a retired consultant obstetrician from the Memorial Hospital in Darlington, says it's time for the UK to follow guidance from the World Health Organisation and the International Federation...
COVINA, Calif., Nov. 11, 2010 /PRNewswire/ -- StemCyte, Inc., one of the world's preeminent umbilical cord blood (UCB) banks and biotherapy companies, is proud to announce that the Company has been awarded two cash grants totaling $488,950 under the U.S. Internal Revenue Service's Qualifying Therapeutic Discovery Project (QTDP) program designed to support biomedical research by firms with fewer than 250 employees. The Patient Protection and Affordable Care Act of 2010 (PPACA) created the...
LAS VEGAS, Nov. 8, 2010 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it is the first cord blood stem cell storage company to become an alliance partner of AHIP (America's Health Insurance Plans), a national association representing nearly 1,300...
LAS VEGAS, Nov. 5 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it is pleased that Congress has approved, and President Obama has signed, the Stem Cell Therapeutic and Research Reauthorization Act of 2010. U.S. Senator Jack Reed (D-RI), co-sponsor of the bill,...
LAS VEGAS, Oct. 28 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells to families nationwide and internationally, is pleased to announce a new work agreement with the Hawaii Medical Service Association (HMSA), an independent licensee of the Blue Cross and Blue Shield Association, the largest and most experienced provider of health...
